Biocon shares jump 8% post Q4 results. Is the Street happy? Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings ...
Biocon Ltd. shares fell after the US Food and Drug Administration issued a Form 483 with five observations for its Bengaluru ...
Biocon said it will submit a comprehensive corrective and preventive action (CAPA) plan within the stipulated timeline and is ...
Bengaluru/Toronto: Biocon is stepping up its global biosimilars play with fresh approvals in Canada, targeting large patient ...
At around 10:42 a.m., Biocon shares were up 1.51 per cent, or Rs 3.6, at Rs 242.05 apiece on BSE. The market capitalisation ...
Hosted on MSN
Biocon to merge biologics unit in $5.5 billion deal
Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the remaining stake in Biocon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results